Sugi Predict

Sugi Predict / Compounds / SCHEMBL269725

SCHEMBL269725

SCHEMBL269725

CC(=O)OB(OC(C)=O)OC(C)=O.[LiH]

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 3/20 0.41
▸ LMNA P02545 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ THPO P40225 1/20 0.31
▸ FFAR3 O14843 1/20 0.31
▸ LCK P06239 1/20 0.31
▸ FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6319 0.96 ALDH1A1 (0.44) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL2547046 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL28578939 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL19518538 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL1528 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL31146798 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
Ammonia Solution, Strong SCHEMBL18860444 0.93 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL23121571 0.90 ALDH1A1 (0.39) ALDH1A1TSHRLMNAHSD17B10TDP1
Water SCHEMBL141331 0.90 ALDH1A1 (0.39) ALDH1A1TSHRLMNAHSD17B10TDP1
SCHEMBL22472309 0.90 ALDH1A1 (0.39) ALDH1A1TSHRLMNAHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116063186-A Process and intermediates for the preparation of (S) -2-amino-5, 7-difluoro-1, 2,3, 4-tetrahydronaphthalene hydrogen halides 江苏亚虹医药科技股份有限公司 2023-05-05 — — CN claimed
CN-114163377-A Preparation method of N-Boc-5-bromoisoindoline 上海馨远医药科技有限公司 2022-03-11 — — CN claimed
CN-111606836-B Preparation method of R-N-Boc-3-pyrrolidineacetic acid 上海馨远医药科技有限公司 2021-01-15 — — CN claimed
CN-111606836-A Preparation method of R-N-Boc-3-pyrrolidineacetic acid 上海馨远医药科技有限公司 2020-09-01 — — CN claimed
EP-3395797-B1 COMPOUNDS AS CATIONIC LIPIDS KYOWA KIRIN CO LTD (JP) 2025-08-06 — — EP disclosed
CN-112437768-B Novel functionalized lactams as modulators of 5-hydroxytryptamine receptor 7 and methods of use thereof 英联邦高等教育系统坦普尔大学 2025-06-24 — — CN disclosed
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE BARUCH S. BLUMBERG INSTITUTE 2025-06-19 — — US disclosed
US-20250000989-A1 PYRROLO BENZODIAZEPINE DERIVATIVE, AND CONJUGATE, PREPARATION METHOD AND USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2025-01-02 — — US disclosed
CN-119072467-A Novel diazapine compounds targeting yellow fever virus non-structural 4B (NS 4B) protein and methods of use thereof 巴鲁克斯布伦博格研究所 2024-12-03 — — CN disclosed
WO-2024193691-A1 CONJUGATE OF ANTI-ROR1 ANTIBODY AND PBD COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 江苏恒瑞医药股份有限公司 2024-09-26 — — WO disclosed
US-12037328-B2 Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 PRAMANA PHARMACEUTICALS INC. (CA) 2024-07-16 — — US disclosed
CN-118317784-A Pyrrolo-benzodiazepine derivative and conjugate thereof, and preparation method and application thereof 江苏恒瑞医药股份有限公司 2024-07-09 — — CN disclosed
US-5599927-A HETEROCYCLIC RING, AMINO-, AMIDO- OR ISOCYANAT-ALKYL SUBSTITUTED IMMUNOSUPPRESSANTS; SIDE-EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-02-04 — — US disclosed
US-5498614-A Bridged aza-bicyclic derivatives as substance P antagonist PFIZER INC. (US) 1996-03-12 — — US disclosed
WO-1995015328-A1 MACROCYCLIC IMMUNOMODULATORS WITH NOVEL CYCLOHEXYL RING REPLACEMENTS ABBOTT LABORATORIES (US) 1995-06-08 — — WO disclosed
EP-0550635-B1 FUSED RING ANALOGS OF NITROGEN CONTAINING NONAROMATIC HETEROCYCLES PFIZER (US) 1995-04-19 — — EP disclosed
EP-0641328-A1 BRIDGED AZA-BICYCLIC DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1995-03-08 — — EP disclosed
WO-1993023380-A1 BRIDGED AZA-BICYCLIC DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1993-11-25 — — WO disclosed
EP-0550635-A1 FUSED RING ANALOGS OF NITROGEN CONTAINING NONAROMATIC HETEROCYCLES. PFIZER (US) 1993-07-14 — — EP disclosed
WO-1992006079-A1 FUSED RING ANALOGS OF NITROGEN CONTAINING NONAROMATIC HETEROCYCLES PFIZER INC. (US) 1992-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000989-A1 PYRROLO BENZODIAZEPINE DERIVATIVE, AND CONJUGATE, PREPARATION METHOD AND USE THEREOF GABRA5, GABRA4, GABRA2 ALDH1A1 519/4885TSHR 1596/4885LMNA 3073/4885
US-12037328-B2 Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 GPR119, GPR3, GPR39 ALDH1A1 1111/4885TSHR 510/4885LMNA 4688/4885
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE CUL4B, BRD4, CUL4A ALDH1A1 4616/4885TSHR 3914/4885LMNA 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.